Keeping Track: Ticovac Is Latest Win For Pfizer’s Vaccine Business; Doors Open For BMS And GSK PD-1 Inhibitors

 
• By Bridget Silverman

The latest drug development news and highlights from the Pink Sheet’s US FDA Performance Tracker.

Keeping Track Feature image
GlaxoSmithKline’s Jemperli joined the small group of products with tissue-agnostic cancer therapy indications in the US.

More from Approvals

More from Product Reviews